France· FR:62070450
ZIAGEN 20 mg/ml, solution buvable
A medicinal product containing abacavir (sulfate d'), registered in France by VIIV HEALTHCARE UK (ROYAUME-UNI), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ABACAVIR (SULFATE D')
- Manufacturer
- VIIV HEALTHCARE UK (ROYAUME-UNI)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009361090561 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 240 ml avec seringue(s) doseuse(s) polypropylène polyéthylèneEUR 75.1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Abacavir (sulfate d') in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAbacavirCamber Pharmaceuticals, Inc.
- CzechiaZIAGENViiV Healthcare BV, Amersfoort
- SpainZIAGEN 20 MG/ML SOLUCION ORALViiv Healthcare B.V.
- FinlandZiagenViiV Healthcare BV
- IrelandZiagen 20mg/mL Oral solutionViiV Healthcare BV
- BelgiumZiagen 20 mg/mlViiV Healthcare
- NetherlandsZiagen 20 mg/ml, drankViiV healthcare B.V.
- NorwayZiagenUkjent (2)
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Spain · Abacavir Tarbis
- Finland · Abacavir Accord
- United Kingdom (Northern Ireland) · Abacavir Milpharm, Abacavir Mylan
- Iceland · Ziagen
- Italy · Abacavir Mylan
- Liechtenstein · Ziagen
- Netherlands · Abacavir Accord, Abacavir Sandoz
- Norway · Ziagen
- Portugal · Abacavir Farmoz, Abacavir Generis
- Romania · Abacavir Aurobindo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1dd9bae-73fc-4f4c-aaad-727948216236 GET /v1/drugs/d1dd9bae-73fc-4f4c-aaad-727948216236?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62070450",
"date_amm": "1999-07-08",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/99/112",
"substance": "ABACAVIR (SULFATE D')",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about abacavir (sulfate d').
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.